Other News To Note
Thursday, January 6, 2011
Amira Pharmaceuticals Inc., of San Diego, said findings published in the Journal of Pharmacology and Experimental Therapeutics described the biologic effects and characterization of AM095, a lysophosphatidic acid receptor 1 antagonist in in vitro and in vivo models of fibrotic disease.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.